Free Trial

Cannae Holdings, Inc. (NYSE:CNNE) Shares Sold by Centiva Capital LP

Cannae logo with Finance background

Centiva Capital LP reduced its stake in Cannae Holdings, Inc. (NYSE:CNNE - Free Report) by 74.5% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 104,152 shares of the company's stock after selling 304,573 shares during the quarter. Centiva Capital LP owned about 0.17% of Cannae worth $1,985,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD increased its stake in shares of Cannae by 3.1% in the first quarter. Price T Rowe Associates Inc. MD now owns 43,285 shares of the company's stock worth $963,000 after acquiring an additional 1,312 shares during the period. Jane Street Group LLC boosted its stake in shares of Cannae by 429.2% in the first quarter. Jane Street Group LLC now owns 378,182 shares of the company's stock worth $8,411,000 after buying an additional 306,716 shares during the last quarter. First Hawaiian Bank grew its holdings in Cannae by 34.2% during the second quarter. First Hawaiian Bank now owns 18,390 shares of the company's stock worth $334,000 after acquiring an additional 4,686 shares during the period. CWM LLC raised its position in Cannae by 1,616.0% during the second quarter. CWM LLC now owns 1,390 shares of the company's stock valued at $25,000 after acquiring an additional 1,309 shares in the last quarter. Finally, Shayne & Jacobs LLC lifted its holdings in Cannae by 5.6% in the second quarter. Shayne & Jacobs LLC now owns 86,496 shares of the company's stock valued at $1,569,000 after acquiring an additional 4,590 shares during the period. Hedge funds and other institutional investors own 88.12% of the company's stock.

Cannae Price Performance

Shares of Cannae stock traded down $0.40 on Tuesday, hitting $21.26. The company's stock had a trading volume of 113,103 shares, compared to its average volume of 522,242. The firm has a fifty day moving average price of $19.84 and a 200-day moving average price of $19.23. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.55 and a quick ratio of 2.55. Cannae Holdings, Inc. has a 1 year low of $16.94 and a 1 year high of $22.99.

Cannae (NYSE:CNNE - Get Free Report) last announced its earnings results on Tuesday, November 12th. The company reported ($0.22) earnings per share for the quarter, hitting the consensus estimate of ($0.22). Cannae had a negative return on equity of 8.26% and a negative net margin of 68.61%. The business had revenue of $113.90 million during the quarter, compared to the consensus estimate of $105.67 million. During the same period in the prior year, the company posted ($2.18) EPS. The business's quarterly revenue was down 20.7% on a year-over-year basis. Equities analysts forecast that Cannae Holdings, Inc. will post -2.97 EPS for the current year.

Cannae Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 31st. Stockholders of record on Tuesday, December 17th will be given a $0.12 dividend. The ex-dividend date of this dividend is Tuesday, December 17th. This represents a $0.48 annualized dividend and a dividend yield of 2.26%. Cannae's dividend payout ratio (DPR) is -9.98%.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada raised their price objective on shares of Cannae from $26.00 to $27.00 and gave the stock an "outperform" rating in a research note on Thursday, November 14th.

Check Out Our Latest Report on CNNE

About Cannae

(Free Report)

Cannae Holdings, Inc is a principal investment firm. The firm primarily invests in restaurants, technology enabled healthcare services, financial services and more. It takes both minority and majority stakes. Cannae Holdings, Inc was founded in 2014 and is based in Las Vegas, Nevada.

See Also

Institutional Ownership by Quarter for Cannae (NYSE:CNNE)

→ Did You See Trump’s Bombshell Exec. Order 001? (From Banyan Hill Publishing) (Ad)

Should you invest $1,000 in Cannae right now?

Before you consider Cannae, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cannae wasn't on the list.

While Cannae currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines